5 things you need to know about the drug approval process
Published 7 years ago • 84K plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
22:08
timeline for the drug master review process
-
36:55
components of new drug application and biologics license application (5of15) redi– may 29-30, 2019
-
39:41
referencing approved drug products in anda submissions
-
47:39
new programs and requirements under fdara (5of16) generic drugs forum 2020
-
54:28
overview of non-clinical assessment in drug development (8/14) redi 2017
-
52:19
facility readiness: gmps, quality assessments, and compliance trends (15of16) gdf 2020
-
20:13
quality management maturity: fda vision & expectations (8/15) global quality
-
10:24
regulatory affairs explained episode 1: fda, application types, regulatory pathways & more
-
5:00
who is the u.s. food and drug administration fda
-
19:36
strategies to demonstrate complex api sameness (10of35) complex generics – sep. 25-26, 2019
-
2:15:41
closed session and regular meeting of the mayor and city council - 09/04/2024
-
16:19
referencing approved drug products in anda submissions (9of28) generic drugs forum – apr. 3-4, 2019
-
28:11
post-approval considerations for changes to manufacturing process and facilities - redi 2020
-
46:00
introduction to investigational new drug (ind) applications (3/14) redi 2017
-
20:06
major issues and facilities in drug master files (9/15) global quality
-
56:39
health equity and covid-19: what minority communities need to know
-
18:21
assembling the best team to navigate through preclinical development
-
1:47:48
advancing generic drug development: translating science to approval – day 2 – session 5
-
16:44
generic labeling: strategies for providing high-quality submissions (18/28) generic drugs forum 2017
-
45:48
manufacturing process and controls: avoiding assessment issues (26of28) gdf – apr. 3-4, 2019
-
16:35
application communications – quality assessment perspective
-
3:32:35
forum on transparency at the us food and drug administration